• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Sacubitril/valsartan in HFrEF - Should the aces up our sleeves be played earlier?沙库巴曲缬沙坦用于射血分数降低的心力衰竭——我们的王牌应该更早打出吗？
Int J Cardiol Heart Vasc. 2019 Nov 22;25:100428. doi: 10.1016/j.ijcha.2019.100428. eCollection 2019 Dec.
2
Our Experience With Sacubitril/Valsartan in Chronic Heart Failure Management - HFrEF in the Ambulatory Setting.我们在慢性心力衰竭管理中使用沙库巴曲缬沙坦的经验——门诊射血分数降低型心力衰竭。
Med Arch. 2022 Apr;76(2):101-107. doi: 10.5455/medarh.2022.76.101-107.
3
Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan.沙库巴曲缬沙坦治疗前后心电图结局与射血分数降低的心力衰竭持续时间的关系。
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221107799. doi: 10.1177/10742484221107799.
4
Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study.在新发心力衰竭患者因急性失代偿性心力衰竭住院后不久开始使用沙库巴曲缬沙坦：TRANSITION 研究的亚组分析。
Eur J Heart Fail. 2020 Feb;22(2):303-312. doi: 10.1002/ejhf.1670. Epub 2019 Dec 9.
5
Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients.家庭收入与心力衰竭患者使用沙库巴曲缬沙坦的机会和依从性的关系：一项商业保险患者的回顾性分析。
Circ Cardiovasc Qual Outcomes. 2022 Jul;15(7):e009179. doi: 10.1161/CIRCOUTCOMES.122.009179. Epub 2022 May 13.
6
Effects of sacubitril/valsartan on clinical symptoms, echocardiographic parameters, and outcomes in HFrEF and HFmrEF patients with coronary heart disease and chronic kidney disease.沙库巴曲缬沙坦对冠心病合并慢性肾脏病的射血分数降低心力衰竭和中间射血分数心力衰竭患者临床症状、超声心动图参数及结局的影响。
Curr Med Res Opin. 2021 Jul;37(7):1071-1078. doi: 10.1080/03007995.2021.1908243. Epub 2021 Apr 20.
7
Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis.芪苈强心胶囊联合沙库巴曲缬沙坦治疗射血分数降低的心力衰竭：一项系统评价和Meta分析
Front Pharmacol. 2022 Apr 4;13:832782. doi: 10.3389/fphar.2022.832782. eCollection 2022.
8
Sacubitril/Valsartan in Patients With Heart Failure and Concomitant End-Stage Kidney Disease.沙库巴曲缬沙坦治疗心力衰竭合并终末期肾病患者的疗效。
J Am Heart Assoc. 2022 Sep 20;11(18):e026407. doi: 10.1161/JAHA.122.026407. Epub 2022 Sep 5.
9
Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction.沙库巴曲缬沙坦在肾素-血管紧张素-醛固酮系统抑制剂初治且射血分数降低的心力衰竭退伍军人中的应用。
J Am Heart Assoc. 2021 Oct 19;10(20):e020474. doi: 10.1161/JAHA.120.020474. Epub 2021 Oct 6.
10
Characteristics and Healthcare Utilization Among Veterans Treated for Heart Failure With Reduced Ejection Fraction Who Switched to Sacubitril/Valsartan.接受沙库巴曲缬沙坦治疗的射血分数降低型心力衰竭退伍军人的特征和医疗保健利用情况。
Circ Heart Fail. 2019 Nov;12(11):e005691. doi: 10.1161/CIRCHEARTFAILURE.118.005691. Epub 2019 Nov 13.

本文引用的文献

1
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply.血管紧张素-中性肽链内切酶抑制在射血分数保留的心力衰竭中的应用。回复
N Engl J Med. 2020 Mar 19;382(12):1182-1183. doi: 10.1056/NEJMc2000284.
2
Impact of sacubitril/valsartan on echo parameters in heart failure patients with reduced ejection fraction a prospective evaluation.沙库巴曲缬沙坦对射血分数降低的心力衰竭患者超声心动图参数的影响：一项前瞻性评估
Int J Cardiol Heart Vasc. 2019 Sep 3;25:100418. doi: 10.1016/j.ijcha.2019.100418. eCollection 2019 Dec.
3
Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry.在多尼亚心力衰竭登记处的一组患者中，使用沙库巴曲缬沙坦降低住院费用。
Int J Cardiol Heart Vasc. 2019 Jan 11;22:102-104. doi: 10.1016/j.ijcha.2018.12.009. eCollection 2019 Mar.
4
Switching from ramipril to sacubitril/valsartan favorably alters electrocardiographic indices of ventricular repolarization in heart failure with reduced ejection fraction.从雷米普利转换为沙库巴曲缬沙坦可有益地改变射血分数降低的心力衰竭患者的心室复极心电图指标。
Acta Cardiol. 2020 Feb;75(1):20-25. doi: 10.1080/00015385.2018.1535818. Epub 2018 Dec 4.
5
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.血管紧张素-脑啡肽酶抑制剂在急性失代偿性心力衰竭中的应用。
N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11.
6
Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor.沙库巴曲缬沙坦：一种新型血管紧张素受体脑啡肽酶抑制剂。
Indian Heart J. 2018 Jul;70 Suppl 1(Suppl 1):S102-S110. doi: 10.1016/j.ihj.2018.01.002. Epub 2018 Jan 8.
7
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives.扩张型心肌病中的逆向重构：见解与未来展望。
Int J Cardiol Heart Vasc. 2018 Mar 8;18:52-57. doi: 10.1016/j.ijcha.2018.02.005. eCollection 2018 Mar.
8
Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices.在植入式除颤设备连续远程监测下，比较血管紧张素-脑啡肽酶抑制与血管紧张素抑制对射血分数降低患者室性心律失常的影响。
Heart Rhythm. 2018 Mar;15(3):395-402. doi: 10.1016/j.hrthm.2017.11.012. Epub 2017 Nov 14.
9
Heart failure: preventing disease and death worldwide.心力衰竭：全球范围内预防疾病与死亡
ESC Heart Fail. 2014 Sep;1(1):4-25. doi: 10.1002/ehf2.12005.
10
Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach.沙库巴曲缬沙坦对心脏重塑的作用机制：一种系统生物学方法。
NPJ Syst Biol Appl. 2017 Apr 18;3:12. doi: 10.1038/s41540-017-0013-4. eCollection 2017.

Sacubitril/valsartan in HFrEF - Should the aces up our sleeves be played earlier?

作者信息

Boehmer Andreas A, Ehrlich Joachim R

机构信息

Division of Cardiology, St Josefs-Hospital, Wiesbaden, Germany.

Division of Cardiology, Goethe-University, Frankfurt, Germany.

出版信息

Int J Cardiol Heart Vasc. 2019 Nov 22;25:100428. doi: 10.1016/j.ijcha.2019.100428. eCollection 2019 Dec.

DOI:10.1016/j.ijcha.2019.100428
PMID:31890858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6933444/
Abstract
摘要